Skip to content
HowShorted

Avid Bioservices, Inc. short interest in 2023

In 2023, Avid Bioservices, Inc.'s disclosed short interest ran from 8.32% of shares outstanding on 13 Jan 2023 to 8.94% on 29 Dec 2023, a change of +0.62 percentage points. The year's high was 11.30% on 15 Dec 2023 and its low 7.58% on 28 Feb 2023, averaging 8.83% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.61 days on 15 May 2023. Full history: Avid Bioservices, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Avid Bioservices, Inc. in 2023

2023 in figures

Start of year
8.32% (13 Jan 2023)
End of year
8.94% (29 Dec 2023)
Change
+0.62 pp
High
11.30% (15 Dec 2023)
Low
7.58% (28 Feb 2023)
Average
8.83%
Highest days to cover
17.61 (15 May 2023)
SEC filings marked
7

Every report in 2023

Avid Bioservices, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20238.32%9.24
31 Jan 20238.81%12.07
15 Feb 20237.82%11.93
28 Feb 20237.58%10.99
15 Mar 20239.28%6.3510-Q filed
31 Mar 20237.98%6.67
14 Apr 20238.41%9.91
28 Apr 20238.42%12.05
15 May 20239.66%17.61
31 May 20239.70%11.13
15 Jun 20239.61%16.78
30 Jun 20238.91%4.7210-K filed, results (8-K)
14 Jul 20238.76%12.25
31 Jul 20238.24%9.18
15 Aug 20238.10%10.13
31 Aug 20238.25%11.77
15 Sep 20238.39%6.6810-Q filed, results (8-K)
29 Sep 20238.14%7.81
13 Oct 20237.99%10.40
31 Oct 20238.54%7.29
15 Nov 20239.68%7.87
30 Nov 202311.04%6.48
15 Dec 202311.30%2.1110-Q filed, results (8-K)
29 Dec 20238.94%3.94

See also: Avid Bioservices, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.